Applied Therapeutics, Inc. - APLT
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | Vestal Point Capital, LP | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Ryan Wilder | 0.0% | 0 | View |
| Dec 31, 2025 | SCHEDULE 13G/A | Propel Bio Management, LLC | 4.2% | 6,015,394 | View |
| Dec 31, 2025 | SCHEDULE 13G/A | Leen Kawas | 4.2% | 6,015,394 | View |
| Dec 31, 2025 | SCHEDULE 13G/A | Richard Kayne and Suzanne Kayne Living Trust dtd 01/14/1999 | 0.0% | 0 | View |
| Dec 31, 2025 | SCHEDULE 13G/A | Richard Kayne | 4.2% | 6,015,394 | View |
| Dec 31, 2025 | SCHEDULE 13G/A | Propel Bio Partners LLC | 4.2% | 6,015,394 | View |
| Dec 15, 2025 | SCHEDULE 13G/A | Alexandria Real Estate Equities, Inc. | 4.3% | 6,500,000 | View |
| Dec 15, 2025 | SCHEDULE 13G/A | Alexandria Venture Investments, LLC | 3.0% | 4,450,000 | View |
| Dec 15, 2025 | SCHEDULE 13G/A | Alexandria Equities No. 7, LLC | 1.4% | 2,050,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | T. Rowe Price Investment Management, Inc. | 14.9% | 21,403,300 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.